Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01EX" (53)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Sunitinib (L01EX01) 12 products
WHO-DDD
L
IP
CI
Sunitinib Viatris 12.5 mg
28
800.81
887.35
10 %
Capsules: Sunitinibum 12.5 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
IP
Sunitinib Viatris 25 mg
28
1601.50
1758.15
10 %
Capsules: Sunitinibum 25 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
IP
Sunitinib Viatris 50 mg
28
3046.34
3329.50
10 %
Capsules: Sunitinibum 50 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
SIP
IP
CI
Sutent 12.5 mg
28 Capsule(s)
880.89
969.50
10 %
Capsules: Sunitinibum 12.5 mg
Pfizer AG
A / SL / SO
FB
G
L
SIP
IP
CI
Sutent 25 mg
28 Capsule(s)
1761.64
1922.45
10 %
Capsules: Sunitinibum 25 mg
Pfizer AG
A / SL / SO
FB
G
L
SIP
IP
CI
Sutent 50 mg
28 Capsule(s)
3350.97
3642.05
10 %
Capsules: Sunitinibum 50 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Sunitinib Zentiva 12.5 mg
28
800.81
887.35
10 %
Capsules: Sunitinibum 12.5 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Sunitinib Zentiva 25 mg
28
1601.50
1758.15
10 %
Capsules: Sunitinibum 25 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Sunitinib Zentiva 50 mg
28
3046.34
3329.50
10 %
Capsules: Sunitinibum 50 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Sunitinib-Teva 12.5 mg
28
800.81
887.35
10 %
Capsules: Sunitinibum 12.5 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Sunitinib-Teva 25 mg
28
1601.50
1758.15
10 %
Capsules: Sunitinibum 25 mg
Teva Pharma AG
●
A / SL / SG
FB
G
L
IP
Sunitinib-Teva 50 mg
28
3046.34
3329.50
10 %
Capsules: Sunitinibum 50 mg
Teva Pharma AG
A / SL / SG
FB
G
Sorafenib (L01EX02) 2 products
WHO-DDD
L
SIP
IP
CI
Nexavar
112 Tablet(s)
2869.05
3112.40
10 %
Coated tablets: Sorafenibum 200 mg
Bayer (Schweiz) AG
A / SL / SO
FB
G
L
IP
CI
Sorafenib Zentiva 200 mg
112
2474.29
2707.35
10 %
Coated tablets: Sorafenibum 200 mg
Helvepharm AG
A / SL / SG
FB
G
Pazopanib (L01EX03) 2 products
WHO-DDD
Pazopanib Spirig HC 200 mg
30
PR
PR
k.A.
Coated tablets: Pazopanibum 200 mg
Spirig HealthCare AG
A
FB
G
Pazopanib Spirig HC 400 mg
60
PR
PR
k.A.
Coated tablets: Pazopanibum 400 mg
Spirig HealthCare AG
A
FB
G
Vandetanib (L01EX04) 2 products
WHO-DDD
L
IP
CI
PP
Caprelsa 100 mg
30 Tablet(s)
2126.12
2328.70
10 %
Coated tablets: Vandetanibum 100 mg
Sanofi-Aventis
(Suisse) SA
A / SL
FB
G
L
IP
CI
PP
Caprelsa 300 mg
30 Tablet(s)
4497.43
4907.65
10 %
Coated tablets: Vandetanibum 300 mg
Sanofi-Aventis
(Suisse) SA
A / SL
FB
G
Regorafenib (L01EX05) 1 products
WHO-DDD
L
IP
CI
PP
Stivarga 40 mg
3 x 28 Tablet(s)
2963.85
3239.80
10 %
Coated tablets: Regorafenibum 40 mg
Bayer (Schweiz) AG
A / SL
FB
G
Cabozantinib (L01EX07) 3 products
WHO-DDD
L
IP
PP
Cabometyx 60 mg
30
4670.20
5095.55
10 %
Coated tablets: 2 Active Agents
Ipsen Pharma Schweiz
GmbH
A / SL
FB
G
L
IP
CI
PP
Cabometyx 20 mg
30
4670.20
5095.55
10 %
Coated tablets: Cabozantinibum 20 mg
Ipsen Pharma Schweiz
GmbH
A / SL
FB
G
L
IP
PP
Cabometyx 40 mg
30
4670.20
5095.55
10 %
Coated tablets: Cabozantinibum 40 mg
Ipsen Pharma Schweiz
GmbH
A / SL
FB
G
Lenvatinib (L01EX08) 4 products
WHO-DDD
L
IP
CI
PP
Lenvima 4 mg
30 Capsule(s)
1482.50
1628.70
10 %
Capsules: Lenvatinibum 4 mg
Eisai Pharma AG
A / SL
FB
G
L
IP
CI
PP
Lenvima 10 mg
30 Capsule(s)
1482.50
1628.70
10 %
Capsules: Lenvatinibum 10 mg
Eisai Pharma AG
A / SL
FB
G
IP
CI
Kisplyx 4 mg
30
PR
PR
k.A.
Capsules: Lenvatinibum 4 mg
Eisai Pharma AG
A
FB
G
IP
CI
Kisplyx 10 mg
30
PR
PR
k.A.
Capsules: Lenvatinibum 10 mg
Eisai Pharma AG
A
FB
G
Nintedanib (L01EX09) 2 products
WHO-DDD
L
IP
CI
PP
OFEV 100 mg
60 Capsule(s)
1988.75
2179.30
10 %
Soft capsules: Nintedanibum 100 mg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
PP
OFEV 150 mg
60 Capsule(s)
1988.75
2179.30
10 %
Soft capsules: Nintedanibum 150 mg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
Midostaurin (L01EX10) 2 products
WHO-DDD
IP
CI
PP
Rydapt 25 mg
56
PR
PR
k.A.
Soft capsules: Midostaurinum 25 mg
Novartis Pharma
Schweiz AG
A
FB
G
IP
CI
PP
Rydapt 25 mg
112
PR
PR
k.A.
Soft capsules: Midostaurinum 25 mg
Novartis Pharma
Schweiz AG
A
FB
G
Quizartinib (L01EX11) 5 products
WHO-DDD
VANFLYTA 17.7 mg
14
PR
PR
k.A.
Coated tablets: Quizartinibi Dihydrochloridum 20 mg
Daiichi Sankyo
(Schweiz) AG
A
FB
G
VANFLYTA 17.7 mg
28
PR
PR
k.A.
Coated tablets: Quizartinibi Dihydrochloridum 20 mg
Daiichi Sankyo
(Schweiz) AG
A
FB
G
VANFLYTA 26.5 mg
14
PR
PR
k.A.
Coated tablets: Quizartinibi Dihydrochloridum 30 mg
Daiichi Sankyo
(Schweiz) AG
A
FB
G
VANFLYTA 26.5 mg
28
PR
PR
k.A.
Coated tablets: Quizartinibi Dihydrochloridum 30 mg
Daiichi Sankyo
(Schweiz) AG
A
FB
G
VANFLYTA 26.5 mg
56
PR
PR
k.A.
Coated tablets: Quizartinibi Dihydrochloridum 30 mg
Daiichi Sankyo
(Schweiz) AG
A
FB
G
Larotrectinib (L01EX12) 3 products
WHO-DDD
L
IP
CI
Vitrakvi 25 mg
56
1351.24
1485.95
10 %
Capsules: Larotrectinibum 25 mg
Bayer (Schweiz) AG
A / SL
FB
G
L
IP
Vitrakvi 100 mg
56
5422.83
5871.60
10 %
Capsules: Larotrectinibum 100 mg
Bayer (Schweiz) AG
A / SL
FB
G
L
IP
CI
Vitrakvi 20 mg/ml
100 ml
1932.71
2118.35
10 %
Solution (oral): Larotrectinibum 20 mg/ml
Bayer (Schweiz) AG
A / SL
FB
G
Gilteritinib (L01EX13) 1 products
WHO-DDD
L
IP
CI
Xospata 40 mg
84
15062.96
15762.40
10 %
Coated tablets: Gilteritinibum 40 mg
Astellas Pharma AG
A / SL
FB
G
Entrectinib (L01EX14) 2 products
WHO-DDD
L
IP
CI
Rozlytrek 100 mg
30
817.78
905.80
10 %
Capsules: Entrectinibum 100 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Rozlytrek 200 mg
90
4906.67
5342.05
10 %
Capsules: Entrectinibum 200 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
Capmatinib (L01EX17) 2 products
WHO-DDD
L
IP
CI
Tabrecta 150 mg
120
5503.34
5954.25
10 %
Coated tablets: Capmatinibum 150 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
Tabrecta 200 mg
120
5503.34
5954.25
10 %
Coated tablets: Capmatinibum 200 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
Avapritinib (L01EX18) 5 products
WHO-DDD
IP
CI
Ayvakyt 25 mg
30
PR
PR
k.A.
Coated tablets: Avapritinibum 25 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
Ayvakyt 50 mg
30
PR
PR
k.A.
Coated tablets: Avapritinibum 50 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
Ayvakyt 100 mg
30
PR
PR
k.A.
Coated tablets: Avapritinibum 100 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
Ayvakyt 200 mg
30
PR
PR
k.A.
Coated tablets: Avapritinibum 200 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
Ayvakyt 300 mg
30
PR
PR
k.A.
Coated tablets: Avapritinibum 300 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
Ripretinib (L01EX19) 1 products
WHO-DDD
L
IP
CI
Qinlock 50 mg
90
19135.37
19940.70
10 %
Tablets: Ripretinibum 50 mg
Deciphera
Pharmaceuticals
(Schweiz) AG
A / SL
FB
G
Tepotinib (L01EX21) 1 products
WHO-DDD
L
IP
CI
Tepmetko 225 mg
60
5981.89
6445.20
10 %
Coated tablets: Tepotinibum 225 mg
Merck (Schweiz) AG
A / SL
FB
G
Selpercatinib (L01EX22) 3 products
WHO-DDD
L
IP
CI
Retsevmo 40 mg
56
1958.87
2146.80
10 %
Capsules: Selpercatinibum 40 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
Retsevmo 80 mg
56
3917.73
4277.20
10 %
Capsules: Selpercatinibum 80 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
IP
Retsevmo 80 mg
112
PR
PR
k.A.
Capsules: Selpercatinibum 80 mg
Eli Lilly (Suisse) SA
A
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
